Long-term effects of invasive treatment in patients with a post-thrombolytic Q-wave myocardial infarction

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Research

Background:

• Thrombolytic therapy is a cornerstone in acute myocardial infarction (MI) management.
• Q-wave MI indicates significant myocardial damage.
• Inducible myocardial ischemia post-MI is associated with adverse outcomes.

Purpose of the Study:

• To evaluate the long-term impact of a deferred invasive treatment strategy versus medical management.
• To assess effects on survival and non-fatal cardiac events in patients with post-thrombolytic Q-wave MI and inducible ischemia.

Main Methods:

• A randomized controlled trial involving 751 patients with post-thrombolytic Q-wave MI and inducible ischemia.
• Patients were assigned to either a deferred invasive treatment (angioplasty or bypass surgery) or medical treatment.
• Long-term follow-up (median 11.4 years) for vital status and cardiac events.

Main Results:

• Deferred invasive treatment significantly improved survival rates compared to medical treatment (HR 0.85, p=0.034).
• Subgroup analysis indicated improved survival and reduced non-fatal cardiac events in patients with post-infarction angina.
• No significant benefit was observed in patients with silent myocardial ischemia.

Conclusions:

• A deferred invasive strategy enhances survival in patients with inducible ischemia following Q-wave MI.
• The benefits of invasive treatment are more pronounced in patients presenting with angina.
• This study supports a proactive interventional approach for selected post-MI patients.